Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 13 Mar 24 POS EX Additional exhibits for listing
- 13 Mar 24 424B3 Prospectus supplement
- 15 Feb 24 EFFECT Notice of effectiveness
- 14 Feb 24 424B3 Prospectus supplement
-
13 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Dec 23 S-4 Registration of securities issued in business combination transactions
QTTB similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated December 15, 2023, with respect to the consolidated financial statements of Q32 Bio Inc. included in the Proxy Statement of Homology Medicines, Inc. that is made a part of Amendment No. 3 to the Registration Statement (Form S-4) and related Proxy Statement/Prospectus of Homology Medicines, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 13, 2024